AI Will Have Profound Impact on Pharma and Biotech, Temasek CEO Says

Temasek CEO Dilhan Pillay Sandrasegara says AI will not eliminate the need for software during a discussion with Bloomberg's Lisa Abramowicz at Bloomberg Invest.